Literature DB >> 27663785

Using age-stratified incidence data to examine the transmission consequences of pertussis vaccination.

J C Blackwood1, D A T Cummings2, S Iamsirithaworn3, P Rohani4.   

Abstract

Pertussis is a highly infectious respiratory disease that has been on the rise in many countries worldwide over the past several years. The drivers of this increase in pertussis incidence remain hotly debated, with a central and long-standing hypothesis that questions the ability of vaccines to eliminate pertussis transmission rather than simply modulate the severity of disease. In this paper, we present age-structured case notification data from all provinces of Thailand between 1981 and 2014, a period during which vaccine uptake rose substantially, permitting an evaluation of the transmission impacts of vaccination. Our analyses demonstrate decreases in incidence across all ages with increased vaccine uptake - an observation that is at odds with pertussis case notification data in a number of other countries. To explore whether these observations are consistent with a rise in herd immunity and a reduction in bacterial transmission, we analyze an age-structured model that incorporates contrasting hypotheses concerning the immunological and transmission consequences of vaccines. Our results lead us to conclude that the most parsimonious explanation for the combined reduction in incidence and the shift to older age groups in the Thailand data is vaccine-induced herd immunity.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Disease transmission; Epidemiology; Immunity; Mathematical model; Pertussis

Mesh:

Substances:

Year:  2016        PMID: 27663785      PMCID: PMC5292824          DOI: 10.1016/j.epidem.2016.02.001

Source DB:  PubMed          Journal:  Epidemics        ISSN: 1878-0067            Impact factor:   4.396


  33 in total

1.  Combating pertussis resurgence: One booster vaccination schedule does not fit all.

Authors:  Maria A Riolo; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

2.  Epidemiological evidence for herd immunity induced by acellular pertussis vaccines.

Authors:  Matthieu Domenech de Cellès; Maria A Riolo; Felicia M G Magpantay; Pejman Rohani; Aaron A King
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

3.  The recurrence of whooping cough: possible implications for assessment of vaccine efficacy.

Authors:  P E Fine; J A Clarkson
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

4.  The changing age and seasonal profile of pertussis in Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Diane MacDonald; Wrency Wu; Carol Shaw; Jane Macnabb; Sylvie Champagne; David M Patrick; Scott A Halperin
Journal:  J Infect Dis       Date:  2002-04-22       Impact factor: 5.226

5.  Efficacy of pertussis vaccines: a brighter horizon.

Authors:  N W Preston; T N Stanbridge
Journal:  Br Med J       Date:  1972-08-19

6.  Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries.

Authors:  Mirjam Kretzschmar; Peter F M Teunis; Richard G Pebody
Journal:  PLoS Med       Date:  2010-06-22       Impact factor: 11.069

7.  Efficacy of an acellular pertussis vaccine in Japan.

Authors:  T Aoyama; Y Murase; T Kato; T Iwata
Journal:  J Pediatr       Date:  1985-08       Impact factor: 4.406

8.  Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

9.  A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States.

Authors:  Manoj Gambhir; Thomas A Clark; Simon Cauchemez; Sara Y Tartof; David L Swerdlow; Neil M Ferguson
Journal:  PLoS Comput Biol       Date:  2015-04-23       Impact factor: 4.475

10.  Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.

Authors:  Nasamon Wanlapakorn; Varisara Ngaovithunvong; Thanunrat Thongmee; Preeyaporn Vichaiwattana; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2016-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.